مواقع التدريسيينجامعة الكوفة
Haider Abdulrasool Ridha Al-Sabak
Assistant Professor

Haider Abdulrasool Ridha Al-Sabak

0Publications
0Lectures
0Interests

About

CURRICULUM VITAE

Name: Dr. HAIDER ABDULRASOOL RIDHA ALSABAK
Address: Kindha dist., Kufa, Najaf, Iraq.
Mobile: 009647815339747 , 009647809379737
E mail: [email protected]
[email protected]
Affiliation: Faculty of Medicine, University of Kufa,
Kufa, P. O. Box(18), Najaf, Iraq.
Web site: www.uokufa.edu.iq

Degrees & Certificates:
• Bachelor in Medicine & General Surgery (M.B.Ch.B)
(Oct. 1998 - July 2004)
This degree has been awarded from Faculty of Medicine, University of Kufa, with a (Good) graduation grade, average (72.109), rank (10th). No. of graduated students was (70) in the academic year (2003-2004).
• Fellow of Iraqi Board for Medical Specializations (F.I.B.M.S), (Ph.D.), (M.D). (Oct. 2010 – Oct. 2014)
This degree has been awarded from Iraqi Board for Medical Specializations/ Scientific Council of Dermatology and Venereology, rank (3rd), No. of graduated students was (7) in the academic year (2013-2014).

Internship:
Two years (Feb. 2005 – Jan. 2007).
1. General Medicine & Cardiac care Unit.
2. General surgery, Neurosurgery, Cardiothoracic surgery, Urosurgery, Orthopedic and Fracture surgery.
3. Pediatrics and Premature care unit.
4. Obstetrics and Gynecology.

Residency in Dermatology:
(Sep. 2008 – Oct. 2014)
• Resident doctor in Dermatology in Alsadr Medical City till Sep. 2010.
• Post graduate resident doctor in Dermatology and Cutaneous Surgery, 4 – years residency, in Kufa Center for Dermatology, Iraqi Board For Medical Specializations; to acquire the degree of Fellowship of Iraqi Board For Medical Specializations in Dermatology and Venereology.

Certifications and Positions in the University:
• Board certified as Fellow of Iraqi Board For Medical Specializations in Dermatology and Venereology in 11th Nov. 2014.
• Lecturer Doctor in Dermatology in Kufa Medical Faculty since 4th Feb. 2015.
• Consultant Dermatologist in Alsadr Medical City / Najaf since 15th Feb. 2015.
• Member of Laser research unit in Medical Faculty since March 2015.
• Vice president of assessment committee in Kufa Medical Faculty since March 2015 till 31st Aug. 2017.
• Head of Dermatology Module in the 5th year of Medical students since April 2016.
• Head of Dermatology department in Kufa Medical Faculty.
• Manager of the Council of Kufa University since 1st Sep. 2017.
• Manager of Department of Scholarships & Cultural Relations in the University of Kufa from 1st June 2018 to 31st Aug. 2018.
• Member of both the American Academy of Dermatology and the European Academy of Dermatology and Venereology.

Medical Research:
1. Split Face Comparative Study of Using Fractional Erbium : Glass 1540 nm and Nd : YAG Q-Switched 1064 nm Laser Systems in The Treatment of Melasma, published in Journal of Dermatology Research and Therapy at 14th May 2015.
2. Treatment of Resistant Acral Vitiligo with Fractional Erbium:Yag Laser accepted for publication in the Journal of Contemporary Medical Sciences.
3. Split Face Comparison Study of The Efficacy And Outcome of ND: YAG Laser And Intense Pulsed Light System For Hair Removal.
4. Treatment Of Verruca Vulgaris with Long Pulsed Nd:YAG Laser 1064 nm In Iraqi Patients.

Site of Research:
1. Laser Unit for Medical Research, Faculty of Medicine, University of Kufa, Iraq.
2. Department of Dermatology / Alsadr Medical City / Najaf.

Conferences & Workshops of Attendance & Participation:
• March 2011, 2nd scientific symposium in dermatological diseases & laser techniques, technique of injection of Botox & Filler. College of Medicine/University of Kufa, Najaf, Iraq.
• April 2012, 1st dermatological scientific conference, College of Medicine/University of Theqar, Theqar, Iraq
• Jan. 2013, 4th annual conference of the Iraqi Society of Dermatology & Venereology & technique of injection of Botox & Filler, Ishtar Hotel, Baghdad, Iraq.
• Jan. 2014, 11th annual Orlando Dermatology & Clinical Conference (ODAC) & injection of Botox & Filler, Laser, cutaneous surgery & other dermatological techniques, Champion gate Hotel, Orlando, Florida, USA.
• April 2015, Dubai Derma, Dubai World Dermatology & Laser Conference& Exhibition, Dubai, UAE.
• Royagene (platelet rich plasma) in Tehran, Iran, Oct. 2015.
• 29th Oct. to 1stNov. 2015 Sharm Derma conference in Cairo, Egypt.
• 18-19 Feb. 2016 Najaf Derma, Iraq. In dermatology, Cosmetology, Laser & techniques of PDT and PRP, Najaf, Iraq.
• April 2016, Dubai Derma, Dubai World Dermatology & Laser Conference & Exhibition, Dubai, UAE.
• January 2017 IMCAS World Conference of Aesthetic Dermatology and Cosmetology, Paris, France.
• Basra Derma 19-20 Feb. 2017, Basra, Iraq.
• March 2017, Dubai Derma, Dubai World Dermatology & Laser Conference & Exhibition, Dubai, UAE.
• EADV Congress 13–17 Sep. 2017 (European Academy of Dermatology and Venereology), Geneva, Switzerland.
• AAD Congress 16-20 Feb. 2018 (American Academy of Dermatology) San Diego- California- USA.
• Spring Continental Congress of Dermatology (SCCD) 25-27 April 2018 Tehran – Iran.
• Symposium of Sebapharma company Products, Germany, 23rd – 25th August 2018.
• Sharm Derma conference in Cairo, Sharm Elsheik, Egypt 27th Oct. – 1st Nov. 2019.
• January 2019 IMCAS World Conference of Aesthetic Dermatology and Cosmetology, Paris, France.
• March 2019, Dubai Derma, Dubai World Dermatology & Laser Conference & Exhibition, Dubai, UAE.
• Vice president of Medical Committee in the Carnival of the year of Emam Ali 1440 hegry, Apr. 2019.

Other activities:
• Feb. 2014, successfully completed the University of Louisville Continuing Medical Education & Professional Development course, USA.
• Dec. 2014, successfully completed academic teaching methods course, Academic Teachingand Training Development Center, University of Kufa, Iraq.
• March 2015, successfully completed the scientific & practical course of Laser application in Dermatology & Aesthetic Medicine, Laser Research Unit, Kufa Medical School, Iraq.
• May 2015, Journal of Dermatology Research and Therapy had accepted and published the thesis named above.
• Establishing a specialized courses in Laser applications in the treatment of Dermatological diseases and Cosmetic purposes twice yearly.
• Dec. 2018 the Journal of Contemporary Medical Sciences had accepted and published the thesis named above.
• Apr. 2019 the Indian Journal of Public Health Research & Development had accepted the thesis named above.
• Apr. 2019 the Medical Journal of Kufa Nursing Faculty had accepted the thesis named above.

Research Interests

1

Publications

2
May 2015

Split Face Comparative Study of using Fractional Erbium: Glass 1540 Nanometer and Nd: YAG Q-Switched 1064 Nanometer Laser Systems in the Treatment of Melasma

AuthorsProf.Dr. Azar Hadi Maluki, MD, Dermatology, Dr. Haider Alsabak, MD, Dermatology
JournalJournal of Dermatology Research and Therapy
Abstract

Abstract Background: Melasma is a common skin problem and laser started to be an option of treatment. Objective: To compare between the effectiveness of Erbium:Glass 1540 nm laser and Nd: YAG Q-Switched 1064nm laser in the treatment of melasma. Methods: This comparative split face clinical study was carried out in Laser Research Unit, College of Medicine, University of Kufa, Iraq; for the period from October 2012 to December 2013. Each patient's face was divided into two halves, each half was treated with one of the two laser devices used in this study; Fractional Erbium: Glass 1540nm and Nd: YAG Q-Switched 1064nm lasers. The severity of melasma was assessed before, after treatment and 3 months later with the Modified Melasma Area and Severity Index (MASI) Score and by photographs. Results: The mean Modified MASI scores were reduced in the facial halves treated by Erbium: Glass 1540nm laser (statistically highly significant P value of 0.001) more than those treated by Nd: YAG Q-Switched 1064nm laser (statistically significant P value of 0.022). Conclusion: The treatment was well tolerated and patients demonstrated positive responses with promising results. Keywords Melasma, Erbium, Glass laser, Nd, YAG Q-Switched laser

Dec. 2018

Treatment of resistant acral vitiligo with fractional Er:YAG laser

AuthorsProf. Dr. Muhsin Al-Dhalimi, MD, Dermatology, Dr. Haider Alsabak, MD, Dermatology Dr. Aula Hussain, Dermatology
JournalJournal of Contemporary Medical Sciences
Abstract

Objectives To detect the results of treatment of refractory acral vitiligo by combination of fractional erbium-YAG (Er:YAG) 2940 nm laser and narrow band-ultraviolet B (NB-UVB) in comparison with NB-UVB alone. Methods Thirty four patients who had generalized, stable (6 months or more) with resistant acral vitiligo were enrolled. The predominantly affected limbs, lower or upper, were treated with both laser and NB-UVB, while the less predominantly affected limbs were treated with NB-UVB alone. During the treatment period, the patients were seen every 4 weeks regularly. Results The response rate in areas treated with both fractional Er:YAG laser and NB-UVB was as follows: Four patients (13.3%) had good response, six patients (20%) had moderate response and seven patients (23.3%) had poor response and 13 patients (43.3%) had no response. The statistical analysis showed a significant response (P-value <0.001). Conclusion Combination therapy is safe and more effective in the treatment of acral vitiligo than NB-UVB monotherapy. Keywords acral vitiligo, erbium-YAG laser, NB-UVB

Lectures

5
View details